N/A Recruiting
CTNNA1 Familial Expansion Study Sponsored by Abramson Cancer Center at Penn Medicine
About this study The goal of the CAFÉ Study is to determine the cancer risks associated with germline CTNNA1 loss-of-function variants.
Enrolling at this location Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania
I'm interested Study details Conditions
Cancer Gene Mutation Gastric Cancer Breast Cancer
Gender
All genders welcome
Healthy volunteers
Not accepted
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov .
Clinably Connecting patients with clinical research opportunities near them.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you meet the criteria to participate. Results are based on the information you provide and are intended to help you start a conversation with the research team.
© 2026 Clinably. Trial data sourced from ClinicalTrials.gov.